Title : Taking varenicline for smoking cessation: A rare cause of pulmonary thromboembolism with infarction.

Pub. Date : 2017 Jul

PMID : 28268112






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Varenicline (Champix , Chantix ) is a partial agonist of the alpha4beta2 nicotinic acetylcholine receptor (nAChR) and a full agonist of the alpha7 nAChR. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
2 Varenicline (Champix , Chantix ) is a partial agonist of the alpha4beta2 nicotinic acetylcholine receptor (nAChR) and a full agonist of the alpha7 nAChR. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
3 Varenicline (Champix , Chantix ) is a partial agonist of the alpha4beta2 nicotinic acetylcholine receptor (nAChR) and a full agonist of the alpha7 nAChR. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
4 Varenicline (Champix , Chantix ) is a partial agonist of the alpha4beta2 nicotinic acetylcholine receptor (nAChR) and a full agonist of the alpha7 nAChR. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
5 Varenicline (Champix , Chantix ) is a partial agonist of the alpha4beta2 nicotinic acetylcholine receptor (nAChR) and a full agonist of the alpha7 nAChR. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
6 Varenicline (Champix , Chantix ) is a partial agonist of the alpha4beta2 nicotinic acetylcholine receptor (nAChR) and a full agonist of the alpha7 nAChR. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
7 Varenicline has been associated with adverse cardiovascular (CV) events, including myocardial infarction, which may be caused by activation of the alpha7 nAChR receptor that in turn stimulates parasympathetic output from the brainstem to the heart, release of catecholamines, and has a prothrombotic effect. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens